Nesiritide citrate is a recombinant form of human B-type natriuretic peptide (BNP) used in the management of acute decompensated heart failure. It works by promoting vasodilation, natriuresis (excretion of sodium in urine), and diuresis, which helps reduce the workload on the heart and relieve symptoms like shortness of breath. Nesiritide is typically administered via intravenous infusion in hospitalized patients with severe heart failure symptoms. However, its use has declined due to concerns about limited long-term benefits and potential risks including hypotension. It is grouped under the following drug class(es): Peptides and Vasodilating agents. The directory classifies it as a unknown/inactive API with a peptide source/manufacturing origin. Other names for this substance include Natriuretic factor-32 (human brain clone lambdahBNP57), 2-hydroxy-1, 2, 3-propanetricarboxylate (salt), Brain natriuretic peptide-32 (human), 2-hydroxy-1, 2 and 3-propanetricarboxylate (salt). Its PubChem CID is 56841835.
Nesiritide citrate
| CAS No | 189032-40-4 |
|---|---|
| Molecular Formula | C149H252N50O49S4 |
| Molecular Weight | 3656.2 g/mol |
| Synonyms | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(4R,10S,16S,19S,22S,25S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-[(2S)-butan-2-yl]-31,43-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,19,22,25-tetrakis(hydroxymethyl)-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid;2-hydroxypropane-1,2,3-tricarboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nesiritide citrate is a recombinant form of human B-type natriuretic peptide (BNP) used in the management of acute decompensated heart failure.
The listed CAS number is 189032-40-4.
The listed molecular formula is C149H252N50O49S4.
The listed molecular weight is 3656.2 g/mol.
The source lists Natriuretic factor-32 (human brain clone lambdahBNP57), 2-hydroxy-1, 2, 3-propanetricarboxylate (salt), Brain natriuretic peptide-32 (human), 2-hydroxy-1, 2 and 3-propanetricarboxylate (salt).
It is listed under Peptides and Vasodilating agents.